Proposed U.S. tariffs on generic medicines could disrupt global pharmaceutical supply chains

Short summary

The Trump administration plans major tariffs on generic medicines, targeting one of the world's most complex and globalized pharmaceutical supply chains. The move could disrupt drug pricing and availability. India is a major generic drug exporter and could be significantly affected.

• •Trump administration targets generic medicine supply chain with tariffs
• •Pharma supply chain is among the most globalized and complex
• •Potential impact on drug pricing and international trade flows

Generated with AI, which can make mistakes.